Perforated Jejunal Adenocarcinoma in a COVID-19-Positive Patient*

• Autor(a) principal: Cruz,Jorge Said Haro
• Data de Publicação: 2021
• Outros Autores: Degollado,Ana Cristina Díaz, Iturbide,Ricardo García, Gutiérrez,Claudio Daniel Rojas, Macías,Javier Alba, Hernández,Andrei Coria
• Tipo de documento: Relatório
• Idioma: eng
• Título da fonte: Journal of Coloproctology (Rio de Janeiro. Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632021000200210
• topic: adenocarcinoma; COVID-19; intestinal perforation; jejunal neoplasms

Abstract Jejunal adenocarcinoma is a rare type of primary small bowelmalignancy. It is generally diagnosed at late stages and as a surgical finding, with abdominal pain or discomfort being the main associated symptom. Cases presenting with perforation are even rarer, especially without disseminated disease. The relationship between cancer and coronavirus disease 2019 (COVID-19) is still being studied, as well as the postsurgical evolution of COVID-19 patients and its possible causality of intestinal perforation. We present the case of a perforated jejunal adenocarcinoma in a COVID-19-positive patient, in whom the symptomatology secondary to the perforation led to an early diagnosis, treatment and adequate postsurgical evolution, despite the concomitant condition.